Open tender · Germany · Contract notice

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Capsaicin, ATC N01BX04 für die Zeit 01.09.2026 - 31.08.2028 (zzgl. Verlängerungsoption 1x12 Monate)

DAK-Gesundheit

DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Capsaicin, ATC N01BX04 für die Zeit 01.09.2026…”. Bids close on 5 July 2029. To qualify, bidders need at least one similar completed work.

The work

Conclusion of a non-exclusive discount agreement for the active substance Capsaicin (ATC N01BX04) for the period 01.09.2026 - 31.08.2028.

  • Agreement must be concluded for the specified active substance and period.
  • The contract must include the predefined discounts set by DAK-Gesundheit.

Key facts

Contract period
01.09.2026 - 31.08.2028 (with a 1x12 month extension option)
Evaluation
Selection criteria are stated as 'Siehe Antragsschreiben' (See application letter), implying a qualitative assessment of the application itself.

What it takes to qualify

Worth a closer look

  • The tender is for a pharmaceutical rebate agreement, which may have specific regulatory requirements not detailed in the provided text.
  • The text mentions a formal procurement process under the GWB (Gesetz gegen Wettbewerbsbeschränkungen) but states this specific procedure may not fall under cartel procurement law.

Experience

  • At least 1 similar work — Prior experience with pharmaceutical rebate agreements is implied by the context of the tender, but not explicitly stated as a requirement.

Certifications and registrations

ISO 9001 (optional)Not mentioned in the provided text
GST registration (optional)Not mentioned in the provided text

Policy conditions

No reservation, preference or local-content restriction.

Documents to submit

  1. AngebotsschreibenCover letter as part of the application.
  2. Anerkennung der vertraglichen Maßgaben der DAK-GesundheitSubmission of the signed contract with name or company stamp.
  3. Anlage 1 zum VertragFilled-out form to be submitted.
  4. Anlage 2 zum VertragExcel file listing the pharmaceuticals to be included in the contract.